insights_auto
Outlook: 75.0% bullish·0.0% bearish
Go to analysischevron_right
VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$522.84
arrow_upward
+1.26%(+6.50) 1D
Sep 24, 2:17:20 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$515.56
High
$528.99
Low
$515.30
Mkt. cap
132.50B
Avg. vol.
1.05M
Volume
380.57K
P/E ratio
30.42
52-wk high
$560.25
52-wk low
$377.02
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Open
$515.56
High
$528.99
Low
$515.30
Mkt. cap
132.50B
Avg. vol.
1.05M
Volume
380.57K
P/E ratio
30.42
52-wk high
$560.25
52-wk low
$377.02
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
35 minutes ago
Vertex Pharmaceuticals stock tracks kidney pipeline progress
Zacks
·
2 hours ago
Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
Yahoo Finance
·
3 hours ago
Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
Simply Wall Street
·
5 hours ago
What Is Drawing Fresh Attention To Vertex Pharmaceuticals (VRTX)?
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com